CVMP meeting 11-13 July

CVMP had its last meeting in London before the summer break. They had a very busy agenda, amongst it:

  • Pharmacovigilance: 1/ Bravecto case: CVMP recommended amendments to the product information leaflet. 2/ CVMP adopted a revised reflection paper on promotion of pharmacovigilance reporting. The reflection paper further examines issues that may be important to the pharmacovigilance promotion strategy, particularly concerning food-producing animals where under-reporting of adverse events is of concern.
  • Antimicrobial resistance: the committee adopted a draft reflection paper on off-label use of antimicrobials in companion animals and food-producing animals for a 6-months public consultation. The paper explores the off-label use of antimicrobials in animals, the underlying reasons for these practices and the potential implications for animal and human health.

CVMP adopted a draft reflection paper on the use of aminoglycosides in animals in the European Union for a 3-months public consultation. The reflection paper critically reviews the current knowledge on the usage of aminoglycosides, resistance development and the potential impact of this resistance on animal and human health.
Full report